COMP <GO>
MDWD vs BTMD // EV/EBITDA & P/E VALUATION
MediWound Ltd. (NASDAQ) VS. Biote Corp. (Class A) (NASDAQ) • 15-METRIC TALLY: MDWD 2
— BTMD 1
■ METRIC PARITY
LAST: $13.86 (+2.21%) • MKT CAP: $178.9M
valuation
—
LAST: $1.17 (+1.74%) • MKT CAP: $42.0M
valuation
2.9x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MDWD VS. BTMD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MDWD | BTMD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | 85.00% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 2.9x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | 18.50% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | 14.10% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | -2.50% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 4.11% | -4.11 | BTMD | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 2.50 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 6/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.0 | 43.5 | +15.46 | MDWD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $178.9M | $42.0M | $136.9M | MDWD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MDWD REV | BTMD REV | MDWD GROSS % | BTMD GROSS % | MDWD FCF | BTMD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $192.2M | — | — | — | $30.2M |
| FY 2024 | — | $197.2M | — | — | — | $38.8M |
| FY 2023 | — | $185.4M | — | — | — | $26.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MDWD // BETA —
BTMD // BETA —